Lily Chau
-
- Glioma Diagnosis and Treatment 1
-
- Cell death mechanisms and regulation 3
- RNA Interference and Gene Delivery 1
- DNA Repair Mechanisms 1
-
- PARP inhibition in cancer therapy 1
- CAR-T cell therapy research 1
-
- Cancer Research and Treatments 1
- Co-authors
- Chang ShuMarkus D. SiegelinGeorg Karpel‐MasslerJeffrey N. BrucePeter CanollMike‐Andrew WesthoffMarc‐Eric HalatschBasil A. Horst
- Partner nations
- United StatesGermany
In The Last Decade
Lily Chau
3 papers receiving 144 citations
Peers
Comparison fields: 5 of 39
- Cancer Research 33
- Genetics 21
- Molecular Biology 128
- Structural Biology 2
- Cell Biology 21
Countries citing papers authored by Lily Chau
This map shows the geographic impact of Lily Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Chau more than expected).
Fields of papers citing papers by Lily Chau
This network shows the impact of papers produced by Lily Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Chau. The network helps show where Lily Chau may publish in the future.
Co-authorship network
The 16 scholars most cited alongside Lily Chau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 63 | |
| 2 | 2015 | 42 | |
| 3 | 2014 | 39 |
About Lily Chau
Lily Chau is a scholar working on Biotechnology, Genetics and Oncology, having authored 3 papers that have together received 144 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (3 papers), RNA Interference and Gene Delivery (1 paper), PARP inhibition in cancer therapy (1 paper), Glioma Diagnosis and Treatment (1 paper), DNA Repair Mechanisms (1 paper), Cancer Research and Treatments (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Cancer Research (33 citations), Genetics (21 citations) and Molecular Biology (128 citations). Lily Chau has collaborated with scholars based in United States and Germany. Frequent co-authors include Chang Shu, Markus D. Siegelin, Georg Karpel‐Massler, Jeffrey N. Bruce, Peter Canoll, Mike‐Andrew Westhoff, Marc‐Eric Halatsch, Basil A. Horst, Takashi Tsujiuchi and Lloyd A. Greene. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.